The role of piRNA and its potential clinical implications in cancer

Epigenomics

Volumn 7, Issue 6, 2015, Pages 975-984

  Assumpção, Carolina Baraúna ^a   Calcagno, Danielle Queiroz ^b   Araújo, Taíssa Maíra Thomaz ^b   Batista Dos Santos, Sidney Emmanuel ^b   Ribeiro Dos Santos, Ândrea Kely Campos ^b   Riggins, Gregory Joseph ^c   Burbano, Rommel Rodriguez ^a   Assumpção, Paulo Pimentel ^b  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Hosp Univ Joao de Barros Barreto   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cancer biomarker; cancer therapy; epigenetic network; piRNA; PIWI

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; PIWI INTERACTING RNA; SMALL UNTRANSLATED RNA; UNTRANSLATED RNA; ARGONAUTE PROTEIN; PIWIL1 PROTEIN, HUMAN; SMALL INTERFERING RNA; TRANSCRIPTOME;

CANCER GENETICS; CANCER PROGNOSIS; EPIGENETICS; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; ANTIBODY SPECIFICITY; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; NEOPLASMS; PROGNOSIS; RNA INTERFERENCE;

ARGONAUTE PROTEINS; BIOMARKERS; EPIGENESIS, GENETIC; EPIGENOMICS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; NEOPLASMS; ORGAN SPECIFICITY; PROGNOSIS; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, UNTRANSLATED; TRANSCRIPTOME;

EID: 84939785800     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.37     Document Type: Review

References (85)

1. Boumber Y, Issa JP. Epigenetics in cancer, what's the future? Oncology (Williston Park) 25(3), 220-226, 228 (2011).
2. Tsai HC, Baylin SB. Cancer epigenetics, linking basic biology to clinical medicine. Cell Res. 21(3), 502-517 (2011).
3. You JS, Jones PA. Cancer genetics and epigenetics, two sides of the same coin? Cancer Cell 22(1), 9-20 (2012).
4. Sharma A, Heuck CJ, Fazzari MJ et al. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer. Wiley Interdiscip. Rev. Syst. Biol. Med. 2(6), 654-669 (2010).
5. Jin B, Li Y, Robertson KD. DNA methylation, superior or subordinate in the epigenetic hierarchy? Genes Cancer 2(6), 607-617 (2011).
6. Ong CT, Corces VG. Enhancer function, new insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 12(4), 283-293 (2011).
7. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 31(1), 27-36 (2010).
8. Feng S, Jacobsen SE, Reik W. Epigenetic reprogramming in plant and animal development. Science 330, 622-627 (2010).
9. Dawson MA, Kouzarides T. Cancer epigenetics, from mechanism to therapy. Cell 150(1), 12-27 (2010).
10. Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J. Cell. Physiol. 219(2), 243-250 (2009).
11. Choi JD, Lee J. Interplay between Epigenetics and Genetics in cancer. Genomics Inform. 11(4), 164-173 (2013).
12. Bird A. Perceptions of epigenetics. Nature 447(7143), 396-398 (2007).
13. Sabin LR, Delás MJ, Hannon GJ. Dogma derailed, the many influences of RNA on the genome. Mol. Cell 49(5), 783-794 (2013).
14. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 128(4), 669-681 (2007).
15. Baylin SB, Jones PA. A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 11(10), 726-734 (2011).
16. Allis CD, Muir TW. Spreading chromatin into chemical biology. Chembiochem 12(2), 264-279 (2011).
17. Yang G, Lu X, Yuan L. LncRNA, A link between RNA and cancer. Biochim. Biophys. Acta 1839(11), 1097-1109 (2014).
18. Virani S, Colacino JA, Kim JH, Rozek LS. Cancer epigenetics, a brief review. ILAR J. 53(3-4), 359-369 (2012).
19. Chik F, Szyf M, Rabbani SA. Role of epigenetics in cancer initiation and progression. Adv. Exp. Med. Biol. 720, 91-104 (2011).
20. Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR, Smith MA. Epigenetic mechanisms in gastric cancer. Epigenomics 4(3), 279-294 (2012).
21. Hanahan D, Weinberg RA. Hallmarks of cancer, the next generation. Cell 144(5), 646-674 (2011).
22. Hinoue T, Weisenberger DJ, Lange CP et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 22(2), 271-282 (2012).
23. Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours-lessons from the past. Nat. Rev. Clin. Oncol. 10(5), 256-266 (2013).
24. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell 20, 85-93 (1980).
25. Turcan S, Fabius AW, Borodovsky A et al. Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT InhibitorDecitabine. Oncotarget 4(10), 1729-1736 (2013).
26. Borodovsky A, Salmasi V, Turcan S et al. 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. Oncotarget 4(10), 1737-1747 (2013).
27. Fan HX, Tang H. Complex interactions between microRNAs and hepatitis B/C viruses. World J. Gastroenterol. 20(37), 13477-13492 (2014).
28. Pauli A, Rinn JL, Schier AF. Non-coding RNAs as regulators of embryogenesis. Nat. Rev. Genet. 12(2), 136-149 (2011).
29. Iyengar BR, Choudhary A, Sarangdhar MA, Venkatesh KV, Gadgil CJ, Pillai B. Non-coding RNA interact to regulate neuronal development and function. Front. Cell. Neurosci. 8, 47 (2014).
30. Place RF, Noonan EJ. Non-coding RNAs turn up the heat, an emerging layer of novel regulators in the mammalian heat shock response. Cell Stress Chaperones 19(2), 159-172 (2014).
31. Volders PJ, Verheggen K, Menschaert G et al. An update on LNCipedia, a database for annotated human lncRNA sequences. Nucleic Acids Res. 43, D174-D180 (2014).
32. Felekkis K, Touvana E, Stefanou C, Deltas C. MicroRNAs, a newly described class of encoded molecules that play a role in health and disease. Hippokratia 14(4), 236-240 (2010).
33. Mochizuki K, Gorovsky MA. Conjugation-specific small RNAs in Tetrahymena have predicted properties of scan (scn) RNAs involved in genome rearrangement. Genes Dev. 18, 2068-2073 (2004).
34. Yao MC, Chao JL. RNA-guided DNA deletion in Tetrahymena, an RNAi-based mechanism for programmed genome rearrangements. Annu. Rev. Genet. 39, 537-559 (2005).
35. Kapranov P, Cheng J, Dike S et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316, 1484-1488 (2007).
36. Taft RJ, Glazov EA, Cloonan N et al. Tiny RNAs associated with transcription start sites in animals. Nat. Genet. 41, 572-578 (2009).
37. Wei W, Ba Z, Gao M et al. A role for small RNAs in DNA double-strand break repair. Cell 149(1), 101-12 (2012).
38. Phuah NH, Nagoor NH. Regulation of microRNAs by natural agents, new strategies in cancer therapies. Biomed. Res. Int. 2014, 804510 (2014).
39. Ha T. MicroRNAs in human diseases, from cancer to cardiovascular disease. Immune Netw. 11(3), 135-154 (2011).
40. Paulmurugan R. MicroRNAs-A new generation molecular targets for treating cellular diseases. Theranostics 3(12), 927-929 (2013).
41. Watanabe T, Lin H. Post-transcriptional regulation of gene expression by Piwi proteins and piRNAs. Mol. Cell 56(1), 18-27 (2014).
42. Weick EM, Miska EA. piRNAs, from biogenesis to function. Development 141(18), 3458-3471 (2014).
43. Zheng X, Zhu J, Kapoor A, Zhu JK. Role of Arabidopsis AGO6 in siRNA accumulation, DNA methylation and transcriptional gene silencing. EMBO J. 26, 1691-1701 (2007).
44. Matzke M, Kanno T, Daxinger L, Huettel B, Matzke AJ. RNAmediated chromatin-based silencing in plants. Curr. Opin. Cell Biol. 21, 367-376 (2009).
45. Matzke MA, Mosher RA. RNA-directed DNA methylation, an epigenetic pathway of increasing complexity. Nat. Rev. Genet. 15(6), 394-408 (2014).
46. Wu L, Zhou H, Zhang Q et al. DNA methylation mediated by a microRNA pathway. Mol. Cell 38(3), 465-475 (2010).
47. Ross RJ, Weiner MM, Lin H. PIWI proteins and PIWIinteracting RNAs in the soma. Nature 505(7483), 353-359 (2014).
48. Thomson T, Lin H. The biogenesis and function of PIWI proteins and piRNAs: progress and prospect. Annu. Rev. Cell. Dev. Biol. 25, 355-376 (2009).
49. Han BW, Zamore PD. piRNAS. Curr. Biol. 24(16), 730-733 (2014).
50. Luteijn MJ, Ketting RF. PIWI-interacting RNAs: from generation to transgenerational epigenetics. Nat. Rev. Genet. 14(8), 523-534 (2013).
51. Siomi MC, Sato K, Pezic D et al. PIWI-interacting small RNAs: The vanguard of genome defence. Nat. Rev. Mol. Cell Biol. 12(4), 246-258 (2011).
52. Rajasethupathy P, Antonov I, Sheridan R et al. A role for neuronal piRNAs in the epigenetic control of memory-related synaptic plasticity. Cell 149(3), 693-707 (2012).
53. Wei C, Salichos L, Wittgrove CM, Rokas A, Patton JG. Transcriptome-wide analysis of small RNA expression in early zebrafish development. RNA 18(5), 915-929 (2012).
54. Guo Z, Maki M, Ding R et al. Genome-wide survey of tissue-specific microRNA and transcription factor regulatory networks in 12 tissues. Sci. Rep. 4, 5150 (2014).
55. Esteller M. Cancer epigenomics, DNA methylomes and histone-modification maps. Nat. Rev. Genet. 8(4), 286-298 (2007).
56. Siddiqi S, Matushansky IJ. Piwis and piwi-interacting RNAs in the epigenetics of cancer. Cell. Biochem. 113(2), 373-380 (2012).
57. Zhang G, Pradhan S. Mammalian epigenetic mechanisms. IUBMB Life 66(4), 240-256 (2014).
58. Moreira FC, Assumpção M, Hamoy IG et al. MiRNA expression profile for the human gastric antrum region using ultra-deep sequencing. PLoS ONE 9(3), e92300 (2014).
59. Kvinlaug BT, Huntly BJ. Targeting cancer stem cells. Expert Opin. Ther. Targets 11(7), 915-927 (2007).
60. Cheng J, Guo JM, Xiao BX et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta 412(17-18), 1621-1625 (2011).
61. Cui L, Lou Y, Zhang X et al. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using piRNAs as marks. Clin. Biochem. 44(13), 1050-1057 (2011).
62. Cheng J, Deng H, Xiao B et al. piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Lett. 315(1), 12-17 (2012).
63. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6, 963-968 (1953).
64. Li L, Bhatia R. Stem cell quiescence. Clin. Cancer Res. 17(15), 4936-4941 (2011).
65. Wollenberg B. Implication of stem cells in the biology and therapy of head and neck cancer. GMS Curr. Top. Otorhinolaryngol. Head Neck Surg. 10, Doc01, doi:10.3205/cto000074 (2011) (Epub ahead of print).
66. Shukla S, Meeran SM. Epigenetics of cancer stem cells, pathways and therapeutics. Biochim. Biophys. Acta 1840(12), 3494-3502 (2014).
67. Sasaki T, Shiohama A, Minoshima S, Shimizu N. Identification of eight members of the Argonaute family in the human genome. Genomics 82(3), 323-330 (2003).
68. Wang Y, Liu Y, Shen X et al. The PIWI protein acts as a predictive marker for human gastric cancer. Int. J. Clin. Exp. Pathol. 25(4), 315-325 (2012).
69. Xie Y, Yang Y, Ji D, Zhang D, Yao X, Zhang X. Hiwi downregulation, mediated by shRNA, reduces the proliferation and migration of human hepatocellular carcinoma cells. Mol. Med. Rep. 11(2), 1455-1461 (2015).
70. Liu X, Sun Y, Guo J et al. Expression of Hiwi gene in human gastric cancer was associated with proliferation of cancer cells. Int. J. Cancer 118, 1922-1929 (2006).
71. Yao Y, Li C, Zhou X et al. PIWIL2 induces c-Myc expression by interacting with NME2 and regulates c-Myc-mediated tumor cell proliferation. Oncotarget 5(18), 8466-8477 (2014).
72. Taubert H, Greither T, Kaushal D et al. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene 26, 1098-1100 (2007).
73. Calcagno DQ, Leal MF, Assumpcao PP, Smith MA, Burbano RR. MYC and gastric adenocarcinoma carcinogenesis. World J. Gastroenterol. 14(39), 5962-5968 (2008).
74. Calcagno DQ, Freitas VM, Leal MF et al. MYC, FBXW7 and TP53 copy number variation and expression in gastric cancer. BMC Gastroenterol. 13, 141 (2013).
75. de Souza CR, Leal MF, Calcagno DQ et al. MYC deregulation in gastric cancer and its clinicopathological implications. PLoS ONE 8(5), e64420 (2013).
76. Qiao D, Zeeman AM, Deng W, Looijenga LH, Lin H. Molecular characterization of Hiwi, a human member of the PIWI gene family whose overexpression is correlated to seminomas. Oncogene 21, 3988-3999 (2002).
77. Lee JH, Schütte D, Wulf G et al. Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum. Mol. Genet. 15, 201-211 (2006).
78. Zhao YM, Zhou JM, Wang LR et al. HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection. Cancer 118, 2708-2717 (2012).
79. Lim SL, Ricciardelli C, Oehler MK, Tan IM, Russell D, Grützner F. Overexpression of piRNA pathway genes in epithelial ovarian cancer. PLoS ONE 9(6), e99687 (2014).
80. Cheng J, Guo JM, Xiao BX et al. piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells. Clin. Chim. Acta 412(17-18), 1621-1615 (2011).
81. Huang G, Hu H, Xue X et al. Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer. Clin. Transl. Oncol. 15(7), 563-568 (2013).
82. Sebastian C. Tracking down the origin of cancer, metabolic reprogramming as a driver of stemness and tumorigenesis. Crit. Rev. Oncog. 19(5), 363-382 (2014).
83. Kasai T, Chen L, Mizutani A et al. Cancer stem cells converted from pluripotent stem cells and the cancerous niche. J. Stem Cells Regen. Med. 10(1), 2-7 (2014).
84. TargetScanHuman. Prediction of microRNA targets. www.targetscan.org
85. Assumpção MB, Moreira FC, Hamoy IG et al. Highthroughput miRNA sequencing reveals a field effect in gastric cancer and suggests an epigenetic network mechanism. Bioinform. Biol. Insights (2015) (In Press).